RF Investment Partners Backs Altro & Amici Pharmaceuticals with Aquimont and Miramar
September 19, 2024
RF Investment Partners announced a platform investment in Long Island-based sister companies Altro and Amici Pharmaceuticals, partnering with Aquimont Capital and Miramar Equity Partners to support growth in the companion animal/veterinary pharmaceutical market. The investment provides flexible debt and equity capital to expand sourcing, manufacturing and distribution capabilities for generic pharmaceuticals that serve both veterinary and human end markets.
- Buyers
- RF Investment Partners, Aquimont Capital, Miramar Equity Partners
- Targets
- Altro Pharmaceuticals, Amici Pharmaceuticals
- Industry
- Pharmaceuticals
- Location
- New York, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Altano Group Acquires Avanti Equine Veterinary Partners
April 6, 2023
Veterinary
Altano Group (Altano Gruppe GmbH) has acquired Avanti Equine Veterinary Partners, adding the U.S.-based equine hospital group to its international network. Avanti—founded in 2017 with seven U.S. locations and more than 140 employees—will be integrated into Altano's expanding equine clinic platform to strengthen the group's U.S. presence and specialist capabilities.
-
Aldine and Partners Invest in AmPharm; Compass Group and Partners Invest in New Age Medical
June 24, 2021
Healthcare Services
Aldine Capital Partners provided subordinated-note and equity investments in two healthcare businesses: AmPharm, an institutional long-term care pharmacy (alongside Mitchell Family Office), and New Age Medical, a value-added spinal implant and orthopedic distributor. Compass Group Equity Partners led a strategic growth investment in New Age Medical with additional capital from SunGate Capital, Aldine Capital, and Olympus Ventures to support national expansion and further build infrastructure and business development capabilities.
-
Aquiline Makes Majority Investment in Pharma Force Group LLC
December 31, 2023
Healthcare Services
Aquiline Capital Partners has made a majority investment in Pharma Force Group LLC, a U.S.-based provider of 340B administration software and pharmacy benefits management solutions. The partnership will support PharmaForce’s product expansion and strategic M&A plans to accelerate growth across hospitals and health clinics. Piper Sandler advised PharmaForce; transaction closed in Q4 2023 with financial terms undisclosed.
-
Trilantic North America Makes Minority Investment in Rarebreed Veterinary Partners
September 28, 2020
Healthcare Services
Trilantic North America closed a substantial minority investment in Rarebreed Veterinary Partners, a Portland, Maine–based, technology-enabled veterinary services platform. The investment will fund Rarebreed's growth plan; co-founders Dan Espinal and Sean Miller retain meaningful equity and will continue to lead the business. Existing equity investors Caremi Investments, Northwood Ventures and Halle Capital Management also participated in the financing round.
-
Ampersand Capital Partners Invests in Alliance Pharma
November 18, 2021
Healthcare Services
Ampersand Capital Partners has made a growth equity investment in Alliance Pharma, a Malvern, Pennsylvania–based bioanalytical CRO. The funding will support Alliance’s expansion of global reach, scientific capabilities, and operational capacity while founder Frank Li remains a significant shareholder.
-
TowerBrook Capital Partners Makes Majority Investment in AQUAchiara
July 3, 2024
Food & Beverage
TowerBrook Capital Partners has made a majority equity investment in AQUAchiara, a Paris-based provider of micro-filtered water dispenser solutions for hotels, restaurants and corporate clients. The investment will support AQUAchiara's growth plans — both organic and via strategic acquisitions — and advance TowerBrook's impact strategy, TowerBrook Delta.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.